the drug stocks moved up after hearing about that. we have johnson here to talk about these things. at the end of the day even though the pertain is good it won t change that much for the form suit calpharmaceutical com. that s why we saw them trade higher. let s look at some of the details. we have three of the companies. what happened on friday, this is the reaction you are talking about. a few of the ideas is give the government better leverage with the drug companies. critics are saying it won t effect their pricing and it may or may not give money in the hands of the u.s. consumers. these are the pharmacy benefit managers when you heard this on friday. you have express scripts and
let them compete for lower prices. so seniors get to choose. incentivize it by giving more rebates to seniors. so seniors will pay less for the prescription drug. that s the second thing. and the third is list prices and this is huge and the secretary was talking about this this morning. list prices mean. this the drug company says here s what you have to pay and it s an overinflated price so everyone comes in and they game the system. middle level manager and pharmacy benefit manager, express scripts, some other manager says we ll take our cut, you take your cut. and the patient gets blown over with this. they don t get the benefit that they should and the cost of health care goes way up. julie: whenever you go to spend or buy, i always believe everything is negotiable and our prescription drugs should be as well. and why is it that people in germany are paying less for their prescription drugs than we are here in america? we should be entitled to the same benefits. that s exactly
cvs said it would by aetna, disney buying fox, cigna bought to buy express scripts. but no opposition to any of those deals. which whether opposition to the at&t deal is politically motivated. this is a deal we with ll no approve in my administration because it will too much concentration of power in the hands of too few. but if you want to talk about too much power in the hands of too few, shouldn t we at least be asking about amazon, apple, facebook and google? in a moment an nyu professor whose students get recruited by these giants, despite his personal view that, quote, these behemoths enjoy unfettered domination and hoard riches on a scale not seen since the monopolies of the gilded age. how big are they?
november. but a lot has happened since then. cvs said it would buy etna and signa sought to buy express scripts. but there s been no justice department opposition to any of those deals. which begs the question of whether opposition to the at&t/time warner deal is politically motivated. after all, president trump has been a vocal critic. at&t is buying time warner and thus cnn. a deal we will not approve in my administration because it s too much concentration of power in the hands of too few. but if you want to talk about too much power in the hands of too few, shouldn t we at least be asking about amazon, apple, facebook and google? in a moment, an nyu professor whose students get recruited by the giants who in his view, they
lower. and the insurance companies blame both of them, saying for whatever reason, prices are just too high. so is there any way to solve this problem? for the actual retail price of a drug to go down would take either government intervention or for the marketplace to actually respond and lower the price. we are nearing a crisis point is what americans can afford for medications. and it is scary. and as far as we can tell there s no breaks on it at this point. congress may have a few things up its sleeve. but we re still waiting. and the pbms you might be familiar with, express scripts or cvs or united health care. president trump wanted medicare to negotiate prices directly with the drug companies, the theory being if it costs less for medicare, it would drive prices down for everyone else. but there is this little thing that many of you know about, medicare part d, that makes it tough. in 2003 congress passed a